http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP10010675-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
filingDate 2010-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8f346424cdc1976272a1c2b59b5afbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e852101d75ef9d7691d96dc83f051fb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b56112180bce11d72ca317624b9da762
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed31b9223e4feb3f34c872dbc254b68d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eedda3a2ee130583d927974dfb4c5df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5001e58dc866f88c3f9a8204090dda39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20181d430926e525b153eb79066b610e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce946377f98f7729a0265142c8174d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1643dc3b96aa261686cbc16ec0d038ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76001591dad77ddb793e6f627616ce5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_455aee47d5d396d6b236bf8536676466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bdd9bb0f92542de48557f1830756e81
publicationDate 2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP10010675-A
titleOfInvention DIAMINO-PYRIDINE, PYRIMIDINE, AND PYRIDAZINE MODULATORS OF HISTAMINE RECEIVER H4
abstract Diamino-pyridine, pyrimidine and pyridazine compounds that can be used as modulators of the H4 receptor, and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by the activity of the H4 receptor, such as allergy, asthma , autoimmune diseases, and pruritus.
priorityDate 2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415224349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9259

Total number of triples: 71.